Treatment of paroxysmal nocturnal hemoglobinuria in the era of eculizumab.
about
Eculizumab for treating patients with paroxysmal nocturnal hemoglobinuriaEculizumab for treating patients with paroxysmal nocturnal hemoglobinuriaComplement inhibitors to treat IgM-mediated autoimmune hemolysisExpression and function of hematopoiesis-stimulating factor receptors on the GPI(-) and GPI(+) hematopoietic stem cells of patients with paroxysmal nocturnal hemoglobinuria/aplastic anemia syndrome.How I manage aplastic anaemia in children.New perspectives on the thrombotic complications of haemolysis.How to manage patients with hereditary haemorrhagic telangiectasia.Interim analysis of post-marketing surveillance of eculizumab for paroxysmal nocturnal hemoglobinuria in Japan.Serologic response to meningococcal vaccination in patients with paroxysmal nocturnal hemoglobinuria (PNH) chronically treated with the terminal complement inhibitor eculizumab.Persisting hyperbilirubinemia in patients with paroxysmal nocturnal hemoglobinuria (PNH) chronically treated with eculizumab: The role of hepatocanalicular transporter variants.No Relapse of Calcineurin Inhibitor-Associated Thrombotic Microangiopathy after Discontinuation of Eculizumab.Antibody mediated rejection associated with complement factor h-related protein 3/1 deficiency successfully treated with eculizumab.The Role of Whole-Body Magnetic Resonance Imaging (WB-MRI) in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)
P2860
Q24193045-42DED35A-A592-41B7-B575-5BDEC8A21E01Q24201126-F61A3D5A-6590-466C-8573-FA775CE9E5E2Q26777628-0FE2EB8B-AF52-4336-9E0F-1BC38DC51510Q36824622-1D50ABEA-96CA-4BE3-A2AE-9DE108AA6E94Q37986162-2DD7A9DA-E957-4BD8-9D06-0BA800C6CBB3Q38259274-6FD80DBC-B51D-445D-8018-859C2D2B4C0EQ38552986-24F1ADC7-20AD-4D5F-8BDB-B531EABF80A5Q39554119-468DE0C3-274B-4E60-A3A2-571D65FB3602Q40357752-FE121A57-C0C1-47E5-8CE6-D6310B6933ECQ48152299-86F6C5C9-B401-4137-BD7A-EF56994DF2CBQ50025315-E73300F2-B8D7-400F-AAD2-4F1F7DC79709Q51333222-3718CB4E-0288-451D-AFE1-2477AD67B1A8Q58759598-32731BCB-4BA7-4CBA-8C7D-6A3FBF630F88
P2860
Treatment of paroxysmal nocturnal hemoglobinuria in the era of eculizumab.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Treatment of paroxysmal nocturnal hemoglobinuria in the era of eculizumab.
@en
Treatment of paroxysmal nocturnal hemoglobinuria in the era of eculizumab.
@nl
type
label
Treatment of paroxysmal nocturnal hemoglobinuria in the era of eculizumab.
@en
Treatment of paroxysmal nocturnal hemoglobinuria in the era of eculizumab.
@nl
prefLabel
Treatment of paroxysmal nocturnal hemoglobinuria in the era of eculizumab.
@en
Treatment of paroxysmal nocturnal hemoglobinuria in the era of eculizumab.
@nl
P2860
P1476
Treatment of paroxysmal nocturnal hemoglobinuria in the era of eculizumab.
@en
P2093
Alexander Röth
Ulrich Dührsen
P2860
P304
P356
10.1111/J.1600-0609.2011.01701.X
P577
2011-12-01T00:00:00Z